Answer the genral Pharmacology part for my MBBS professional exams and include relevant diagrams
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Here is a complete, exam-ready answer for all 16 General Pharmacology topics from your Paper I:
General Pharmacology - MBBS Professional Exam Answers
1. Advantages and Disadvantages of Different Routes of Drug Administration
Oral Route
Advantages: Safe, convenient, self-administered, economical, no sterility required
Disadvantages: Slow onset, first pass metabolism reduces bioavailability, unsuitable if vomiting/unconscious, irritant drugs damage GI mucosa, food may impair absorption
Sublingual (SL) Route
Advantages: Rapid absorption, bypasses first pass metabolism (e.g., GTN tablet), quick onset
Disadvantages: Unpleasant taste, only for lipid-soluble drugs, small doses only
Rectal Route
Advantages: Used when oral route unavailable (unconscious, vomiting children), partial bypass of first pass (50%)
Disadvantages: Incomplete/irregular absorption, patient inconvenience
Intravenous (IV) Route
Advantages: 100% bioavailability, immediate effect, accurate titration, useful in emergencies, large volumes possible
Disadvantages: Risk of infection/thrombophlebitis, irreversible - no recall, specialized personnel required, expensive
Intramuscular (IM) Route
Advantages: Faster than oral, depot preparations possible (e.g., Depo-Provera), moderately large volumes
Disadvantages: Painful, risk of nerve/vessel injury, variable absorption with poor perfusion
Subcutaneous (SC) Route
Advantages: Sustained release, self-administration possible (e.g., insulin)
Disadvantages: Only small volumes (max 2 mL), painful, necrosis if irritant drug
Inhalation
Advantages: Direct delivery to lungs (asthma), rapid action, low systemic side effects
Disadvantages: Difficult technique (metered dose inhalers), dose difficult to control
Transdermal Route
Advantages: Sustained release, bypasses first pass metabolism, non-invasive (e.g., GTN patch, nicotine patch)
Disadvantages: Slow onset, only for highly lipid-soluble drugs with low molecular weight
ROUTE COMPARISON TABLE
─────────────────────────────────────────────────────────
Route | Onset | Bioavail. | Examples
─────────────────────────────────────────────────────────
IV | Seconds | 100% | Morphine, Lignocaine
IM | 10-30 min | ~75-100% | Penicillin, Vaccines
SC | 15-30 min | ~75-100% | Insulin, Heparin
Oral | 30-90 min | Variable | Aspirin, Metformin
Sublingual | 1-2 min | High | GTN, Buprenorphine
Rectal | 5-30 min | ~50% | Diazepam, Paracetamol
Transdermal | Hours | Moderate | GTN, Scopolamine
Inhalation | Minutes | High | Salbutamol, Steroids
─────────────────────────────────────────────────────────
2. Generic and Chemical Name of Drugs
Concept
Definition
Example
Chemical name
Full IUPAC name describing molecular structure
N-(4-hydroxyphenyl)acetamide
Generic (Non-proprietary) name
Approved official name (INN - International Nonproprietary Name)
Exam tip: The generic name is written in lowercase; brand names start with a capital letter. Prescriptions should use generic names (INN) to avoid confusion and reduce cost.
3. Special Drug Delivery Systems Including Transdermal Drug Delivery System (TDDS)
Note (Katzung): Displacement from protein binding alone rarely causes clinically significant interactions because the displaced drug is immediately redistributed and eliminated. The interaction is clinically relevant only if the displacing drug also inhibits clearance.
8. First Pass Metabolism
Definition: The metabolism of a drug that occurs in the gut wall and liver before it enters the systemic circulation, following oral administration.
Pathway:
ORAL DRUG → GI Lumen → Gut Wall (CYP3A4) → Portal Vein
↓
Liver (CYP450 enzymes)
↓
SYSTEMIC CIRCULATION (reduced amount)
Result:
Only a fraction of the administered dose reaches systemic circulation
This reduces bioavailability
Drugs with High First Pass Effect (>70% extraction):
Morphine (oral bioavailability ~25%)
Propranolol (oral bioavailability ~25%)
Lidocaine (given IV only for arrhythmia - ~3% oral bioavailability)
GTN (oral bioavailability <1%)
Aspirin
Salbutamol (significant)
Testosterone (extensive first pass → use methyltestosterone or patches)
Ways to Bypass First Pass:
Sublingual (GTN tablet)
Transdermal (GTN patch)
Rectal (partial bypass ~50%)
Parenteral (IM, IV, SC)
Inhalation
Factors affecting first pass:
Blood flow to liver (reduced in liver disease → ↑ bioavailability of high extraction drugs)
Enzyme induction/inhibition
Gut wall metabolism (CYP3A4)
9. Bioavailability
Definition: The fraction (proportion) of administered drug dose that reaches the systemic circulation in an unchanged, pharmacologically active form.
Formula:
Bioavailability (F) = AUC oral / AUC IV × 100%
AUC = Area Under the Plasma Concentration-Time Curve
Relative: Compared to another oral formulation (reference standard)
Factors Affecting Bioavailability:
Route of administration (IV = 100%)
First pass metabolism (reduces oral bioavailability)
Gut motility (faster = less absorption)
Food (can increase or decrease)
Drug formulation (particle size, excipients)
Drug solubility and dissolution
Liver/gut wall enzyme activity
Drug-drug interactions (e.g., antacids reduce absorption of fluoroquinolones)
Route
Approximate Bioavailability
IV
100%
IM
75-100%
Oral
5-100% (variable)
Sublingual
50-75% (bypasses first pass)
Rectal
~50%
Transdermal
Variable (low to moderate)
10. Why is Omeprazole Given on an Empty Stomach in the Morning?
This is a classic exam question with a detailed pharmacological explanation:
Mechanism of Action of Omeprazole:
Omeprazole is a Proton Pump Inhibitor (PPI)
It is a prodrug - converted to active sulphenamide in acidic canalicular pH of parietal cells
Active form irreversibly inhibits H+/K+ ATPase (the proton pump) on the luminal surface of parietal cells
Why empty stomach?
1. Acid-labile nature:
Omeprazole is unstable in gastric acid (degrades at low pH)
Taken as enteric-coated capsule to protect from gastric acid
The enteric coating dissolves in the small intestine (alkaline pH)
2. Proton pumps must be ACTIVE to be inhibited:
Omeprazole only inhibits pumps that are actively secreting acid
Maximum number of active proton pumps are present after fasting (especially overnight fast)
After meals, many pumps are already cycling/synthesizing
Fasting → pumps recruited to canalicular membrane → ready to be inhibited
3. Morning dosing:
After overnight fast, most pumps are active in the morning
A meal after taking omeprazole stimulates acid secretion and activates the pumps
Omeprazole is then present in bloodstream to inhibit these active pumps
Optimal: Take 30-60 minutes BEFORE breakfast
SEQUENCE FOR MAXIMUM EFFECT:
Overnight fast → Proton pumps recruited
↓
Take Omeprazole (30-60 min before breakfast)
↓
Omeprazole absorbed from small intestine
↓
Circulates to parietal cell → converted to sulphenamide
↓
Eat breakfast → Stimulates acid secretion → Pumps activated
↓
Active sulphenamide irreversibly binds active H+/K+ ATPase
↓
Maximum acid suppression achieved
Key point: Evening/bedtime dosing is LESS effective because nocturnal acid secretion does not involve maximum pump recruitment. However, for nocturnal symptoms/GERD, twice-daily dosing is used.
11. Zero Order and First Order Kinetics
First Order Kinetics (Exponential):
A constant FRACTION (%) of the drug is eliminated per unit time
Rate of elimination is proportional to drug concentration
At higher concentration → faster elimination (but same fraction)
Produces a straight line on semi-log plot
Has a constant half-life
Most drugs at therapeutic concentrations follow first order kinetics
FIRST ORDER: Cp vs Time (Semi-log)
Log Cp | ─────────
│ ────────────
│ ────────
└────────────────────────────────▶ Time
(STRAIGHT LINE)
Zero Order Kinetics (Linear):
A constant AMOUNT of drug is eliminated per unit time
Occurs when elimination mechanisms are saturated (capacity-limited)
Rate does NOT depend on concentration (fixed amount per hour)
Produces a straight line on linear plot
Half-life is NOT constant - increases as concentration rises
Small dose changes → disproportionately large changes in plasma level (DANGEROUS)
ZERO ORDER: Cp vs Time (Linear)
Cp | ────────────────────────────────
│ ─────────
└────────────────────────────────────────────▶ Time
(STRAIGHT LINE on linear plot)
Drugs showing zero order at therapeutic doses:
Phenytoin (classic example - "saturation kinetics")
Alcohol (Ethanol) - 10 g/hour metabolized regardless of concentration
Aspirin at high (anti-inflammatory) doses
Michaelis-Menten Kinetics:
Most drugs switch from first order (at low concentrations) to zero order (at high concentrations) when enzymes become saturated. This is described by Michaelis-Menten equation:
v = Vmax × C / (Km + C)
Vmax = maximum elimination rate
Km = concentration at half-Vmax (Michaelis constant)
C = drug concentration
When C << Km → First order
When C >> Km → Zero order
12. Plasma Half Life (t½)
Definition: Time required for the plasma concentration of a drug to fall to half (50%) of its original value.
Formula:
t½ = 0.693 × Vd / CL
Vd = Volume of distribution
CL = Clearance
0.693 = ln2 (natural log of 2)
Significance:
Time to reach steady state: ~4-5 half-lives after starting regular dosing
Time for drug elimination: ~4-5 half-lives for 97% elimination
Dosing interval: Usually equal to one half-life
Loading dose: May be needed if t½ is long (e.g., digoxin)
ACCUMULATION TO STEADY STATE
% Steady │
state │ ─────────── 100%
achieved │ ───────
│ ───────
│ ──────
└──────────────────────────────▶
1 2 3 4 5 (number of t½)
Clinical Examples:
Drug
t½
Clinical Implication
Digoxin
36 hours
Once daily dosing; takes ~1 week to steady state
Aspirin
15-20 min (metabolite 4-6 hr)
Warfarin
36-42 hours
INR takes 3-4 days to stabilize
Penicillin G
30 min
4-6 hourly dosing needed
Amiodarone
40-55 days
Very long - drug interaction concerns
Thiopentone
Short distribution t½ (short action) but long elimination t½
Cumulation on repeated dosing
13. Therapeutic Drug Monitoring (TDM)
Definition: Measurement of drug concentrations in biological fluids (usually plasma) to optimize drug therapy by maintaining levels within the therapeutic window.
Placebo: Inert substance identical in appearance to test drug
Crossover: Each patient receives both treatments sequentially
Informed consent: Mandatory ethical requirement
16. Adverse Drug Reactions (ADR)
Definition: Any noxious, unintended, and undesired effect of a drug that occurs at doses used in humans for prophylaxis, diagnosis, or therapy. (WHO definition)
Classification (Rawlins & Thompson - Type A & B):
Type A (Augmented) - PREDICTABLE, dose-dependent:
Extension of pharmacological effect
Most common (80% of ADRs)
Example: Bleeding with Warfarin, Hypoglycemia with Insulin, Bradycardia with Propranolol
Type B (Bizarre) - UNPREDICTABLE, dose-independent:
Not related to pharmacological action
Immunological (allergy) or genetic (idiosyncratic) mechanisms
Example: Anaphylaxis with Penicillin, Aplastic anemia with Chloramphenicol, Malignant hyperthermia with Succinylcholine
Type C (Chronic): Occur with prolonged use - e.g., Adrenal suppression with long-term steroids
Type D (Delayed): Appear long after drug exposure - e.g., Carcinogenesis (DES), Teratogenicity
Type E (End of treatment): Withdrawal reactions - e.g., Opioid withdrawal, Rebound hypertension with Clonidine
Type F (Failure): Unexpected failure of therapy - e.g., Resistance
Grading of ADR Severity:
Mild: No therapy required, not disabling (e.g., mild nausea)
The science of monitoring drug safety post-marketing
Yellow Card Scheme (UK) / MedWatch (USA) / PVPI (India) - systems for ADR reporting
Naranjo Algorithm - tool to assess causality of ADR (Definite/Probable/Possible/Doubtful)
Common ADR Examples:
Drug
ADR
ACE inhibitors
Dry cough (bradykinin accumulation)
Aminoglycosides
Nephrotoxicity, Ototoxicity
Chloramphenicol
Aplastic anemia, Grey baby syndrome
Metformin
Lactic acidosis
Statins
Myopathy, Rhabdomyolysis
Quinolones
Tendon rupture, QT prolongation
Clozapine
Agranulocytosis
Halothane
Hepatitis
Sulfonamides
Stevens-Johnson syndrome
References: Katzung's Basic and Clinical Pharmacology 16e; Goodman & Gilman's Pharmacological Basis of Therapeutics; KD Tripathi's Essentials of Medical Pharmacology
Study tip for exams: Topics 8, 9, 11, 12 often come together as linked questions on pharmacokinetics. ADR classification (Type A-F), anaphylaxis management, and teratogenic drugs are high-yield short answer/essay topics. Always draw labeled diagrams for dose-response curves, half-life curves, and the transdermal patch structure.
Create a PDF cheat sheet with all 16 General Pharmacology topics
High-yield exam tip: OP poisoning management (Atropine + Pralidoxime), MG treatment (Pyridostigmine), beta-blocker classification, and glaucoma drug mechanisms are the most frequently tested questions in this section.
This is a shared conversation. Sign in to Orris to start your own chat.